sb 216763 has been researched along with Alveolar Bone Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamowicz, K; Jotwani, R; Potempa, J; Scott, DA; Wang, H; Zeller, I | 1 |
1 other study(ies) available for sb 216763 and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice.
Topics: Alveolar Bone Loss; Animals; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Inflammation; Interleukin-17; Maleimides; Maxilla; Mice; Neutrophil Infiltration; Porphyromonas gingivalis; Toll-Like Receptors | 2012 |